ALTRAPHARMA Invest ApS: Financial statements 2017
CVR: 34483884
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ALTRAPHARMA Invest ApS (CVR 34483884) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 472,517 and a net result of DKK 269,891 compared with DKK 67,430 the year before. That is a decrease of 59.1% compared with the year before. Equity in the 2017 report amounted to DKK 516,710. The solvency ratio was 28.2%.
- Gross Profit
- DKK 472,517
- Profit/Loss
- DKK 269,891
- Equity
- DKK 516,710
- Total Assets
- DKK 1,833,528
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 473 t. | 270 t. | 517 t. | 0 |
| 2016 | - | 1.2 mio. | 67 t. | 247 t. | 0 |
| 2015 | - | 843 t. | 7 t. | 379 t. | - |
| 2014 | - | 1.4 mio. | 223 t. | 623 t. | - |
| 2013 | - | 1.4 mio. | 145 t. | 650 t. | - |
Official annual report
Keep an eye on ALTRAPHARMA Invest ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ALTRAPHARMA Invest ApS has published its annual report for 2016. Gross profit came to DKK 1,154,215, and the net result was DKK 67,430.
About ALTRAPHARMA Invest ApS
ALTRAPHARMA Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2012. The company is registered under the industry Anden teknisk rådgivning. The company was previously named ALTRAPHARMA ApS. The management consists of Marianne Thrane. The company is owned by ALTRA 14 ApS and Juniwik Business Management AB. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -88,915 and a net result of DKK -84,944 compared with DKK 86,556 the year before. Equity in the 2025 report amounted to DKK 103,766.